SAT0165 Improvements in Patient-Reported Outcomes and Workplace and Household Productivity Following 52 Weeks of Treatment with Certolizumab Pegol in Combination with Methotrexate in Dmard-Naïve Early Rheumatoid Arthritis Patients: Results from the C-Early Randomized, Double-Blind, Controlled Phase 3 Study

P. Emery; C.O. Bingham; G.-R. Burmester; V.P. Bykerk; D.E. Furst; X. Mariette; O. Purcaru; G. Coteur; B. VanLunen; M. Weinblatt

doi:10.1136/annrheumdis-2015-eular.1499

SAT0165 Improvements in Patient-Reported Outcomes and Workplace and Household Productivity Following 52 Weeks of Treatment with Certolizumab Pegol in Combination with Methotrexate in Dmard-Naïve Early Rheumatoid Arthritis Patients: Results from the C-Early Randomized, Double-Blind, Controlled Phase 3 Study

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2015-eular.1499 ◽

2015 ◽

Vol 74 (Suppl 2) ◽

pp. 712.2-713 ◽

Cited By ~ 1

Author(s):

P. Emery ◽

C.O. Bingham ◽

G.-R. Burmester ◽

V.P. Bykerk ◽

D.E. Furst ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Early Rheumatoid Arthritis ◽

Patient Reported Outcomes ◽

Certolizumab Pegol ◽

Phase 3 ◽

Double Blind ◽

Patient Reported ◽

Household Productivity

Download Full-text

Improvements in Patient-Reported outcomes Following 52 Weeks of Treatment with Certolizumab Pegol in Combination with Methotrexate in Dmard-Naive Patients with Severe, Active and Progressive Rheumatoid Arthritis: Results from the C-Early Randomized, Double-Blind, Controlled Phase 3 Study

Value in Health ◽

10.1016/j.jval.2015.09.2660 ◽

2015 ◽

Vol 18 (7) ◽

pp. A707-A708 ◽

Cited By ~ 2

Author(s):

P Emery ◽

C Bingham ◽

G Burmester ◽

V Bykerk ◽

D Furst ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Patient Reported Outcomes ◽

Certolizumab Pegol ◽

Phase 3 ◽

Double Blind ◽

Patient Reported

Download Full-text

Rapid Improvements In Patient-Reported Outcomes With Certolizumab Pegol In Patients With Axial Spondyloarthritis, Including Ankylosing Spondylitis And Non-Radiographic Axial Spondyloarthritis: 24-Week Results Of A Phase 3 Double Blind Randomized Placebo-Controlled Study

Value in Health ◽

10.1016/j.jval.2013.03.1150 ◽

2013 ◽

Vol 16 (3) ◽

pp. A227 ◽

Cited By ~ 2

Author(s):

J. Sieper ◽

A. Kivitz ◽

A. van Tubergen ◽

A. Deodhar ◽

G. Coteur ◽

...

Keyword(s):

Ankylosing Spondylitis ◽

Patient Reported Outcomes ◽

Axial Spondyloarthritis ◽

Certolizumab Pegol ◽

Controlled Study ◽

Phase 3 ◽

Double Blind ◽

Patient Reported

Download Full-text

SAT0164 The First Study of Certolizumab Pegol in Combination with Methotrexate in Dmard-Naïve Early Rheumatoid Arthritis Patients Led to Sustained Clinical Response and Inhibition of Radiographic Progression at 52 Weeks: The C-Early Randomized, Double-Blind, Controlled Phase 3 Study

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2015-eular.1493 ◽

2015 ◽

Vol 74 (Suppl 2) ◽

pp. 712.1-712

Author(s):

P. Emery ◽

C.O. Bingham ◽

G.-R. Burmester ◽

V.P. Bykerk ◽

D.E. Furst ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Clinical Response ◽

Early Rheumatoid Arthritis ◽

Radiographic Progression ◽

Certolizumab Pegol ◽

Phase 3 ◽

Double Blind

Download Full-text

THU0623 Patient-Reported Outcomes from A Phase 3 Study of Baricitinib in Patients with Early Rheumatoid Arthritis Who Had Received Limited or No Treatment with Disease-Modifying anti-Rheumatic Drugs: Table 1.

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2016-eular.1248 ◽

2016 ◽

Vol 75 (Suppl 2) ◽

pp. 419.1-419 ◽

Cited By ~ 2

Author(s):

M. Schiff ◽

T. Takeuchi ◽

C. Gaich ◽

A.M. DeLozier ◽

D. Schlichting ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Early Rheumatoid Arthritis ◽

Patient Reported Outcomes ◽

Phase 3 ◽

Patient Reported ◽

Disease Modifying

Download Full-text

Improvements in Workplace and Household Productivity Following 52 Weeks of Treatment with Certolizumab Pegol in Combination with Methotrexate in Dmard-Naive Patients with Severe, Active and Progressive Rheumatoid Arthritis: Results from the C-Early Randomized, Double-Blind, Controlled Phase 3 Study

Value in Health ◽

10.1016/j.jval.2015.09.2671 ◽

2015 ◽

Vol 18 (7) ◽

pp. A710 ◽

Cited By ~ 1

Author(s):

P Emery ◽

C Bingham ◽

GR Burmester ◽

VP Bykerk ◽

D Furst ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Certolizumab Pegol ◽

Phase 3 ◽

Double Blind ◽

Household Productivity

Download Full-text

Patient-Reported Outcomes from Two Randomized, Double-Blind, Vehicle-Controlled Phase 3 Trials in Axillary Hyperhidrosis (ATMOS-1 & ATMOS-2)

SKIN The Journal of Cutaneous Medicine ◽

10.25251/skin.1.supp.95 ◽

2017 ◽

Vol 1 ◽

pp. s96

Author(s):

David M Pariser ◽

Adelaide A Hebert ◽

Janice Drew ◽

John Quiring ◽

Dee Anna Glaser

Keyword(s):

Patient Reported Outcomes ◽

Axillary Hyperhidrosis ◽

Phase 3 ◽

Double Blind ◽

Patient Reported

Abstract Not AvailableDisclosure: Study supported by Dermira.

Download Full-text

Patient-Reported Outcomes from Two Randomized, Double-Blind, Vehicle Controlled Phase 3 Trials in Axillary Hyperhidrosis (ATMOS-1 & ATMOS-2)

SKIN The Journal of Cutaneous Medicine ◽

10.25251/skin.2.supp.41 ◽

2018 ◽

Vol 2 ◽

pp. S41

Author(s):

David M Pariser ◽

Adelaide A Hebert ◽

Janice Drew ◽

John Quiring ◽

Dee Anna Glaser

Keyword(s):

Patient Reported Outcomes ◽

Axillary Hyperhidrosis ◽

Phase 3 ◽

Double Blind ◽

Patient Reported

Abstract not available. Disclosures: Study supported by Dermira. Copyright SKIN 2018

Download Full-text

THU0609 Patient-Reported Outcomes from A Phase 3 Study of Baricitinib versus Placebo or Adalimumab in Patients with Active Rheumatoid Arthritis and An Inadequate Response To Background Methotrexate Therapy: Table 1.

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2016-eular.1239 ◽

2016 ◽

Vol 75 (Suppl 2) ◽

pp. 412.2-413 ◽

Cited By ~ 1

Author(s):

E. Keystone ◽

P. Taylor ◽

Y. Tanaka ◽

C. Gaich ◽

A.M. DeLozier ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Patient Reported Outcomes ◽

Active Rheumatoid Arthritis ◽

Methotrexate Therapy ◽

Inadequate Response ◽

Phase 3 ◽

Patient Reported

Download Full-text

Efficacy, safety and patient-reported outcomes of combination etanercept and sulfasalazine versus etanercept alone in patients with rheumatoid arthritis: a double-blind randomised 2-year study

Annals of the Rheumatic Diseases ◽

10.1136/ard.2007.087106 ◽

2008 ◽

Vol 68 (7) ◽

pp. 1146-1152 ◽

Cited By ~ 41

Author(s):

B Combe ◽

C Codreanu ◽

U Fiocco ◽

M Gaubitz ◽

P P Geusens ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Patient Reported Outcomes ◽

Double Blind ◽

Patient Reported

Download Full-text

Long-term disease and patient-reported outcomes of a continuous treat-to-target approach in patients with early rheumatoid arthritis in daily clinical practice

Clinical Rheumatology ◽

10.1007/s10067-017-3962-5 ◽

2018 ◽

Vol 37 (5) ◽

pp. 1189-1197 ◽

Cited By ~ 19

Author(s):

G. A. Versteeg ◽

L. M. M. Steunebrink ◽

H. E. Vonkeman ◽

P. M. ten Klooster ◽

A. E. van der Bijl ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Clinical Practice ◽

Early Rheumatoid Arthritis ◽

Patient Reported Outcomes ◽

Daily Clinical Practice ◽

Treat To Target ◽

Patient Reported

Download Full-text